<- Go Home

Aspira Women's Health Inc.

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

Market Cap

$14.2M

Volume

54.7K

Cash and Equivalents

$962.0K

EBITDA

-$17.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$5.2M

Profit Margin

57.84%

52 Week High

$5.65

52 Week Low

$0.74

Dividend

N/A

Price / Book Value

-3.06

Price / Earnings

-0.62

Price / Tangible Book Value

-3.06

Enterprise Value

$15.6M

Enterprise Value / EBITDA

-0.93

Operating Income

-$17.4M

Return on Equity

753.08%

Return on Assets

-185.71

Cash and Short Term Investments

$962.0K

Debt

$2.4M

Equity

-$3.7M

Revenue

$8.9M

Unlevered FCF

-$8.9M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches